Monday, August 12, 2013

Merck :


  • Merck is into Pharma and Chemicals with revenue split in ratio of 66:34.
  • Pharma includes Merck Serono which includes Neurobion, Polybion, Evion, Livogen, Concor and Consumer health care for cough, cold etc.
  • Imports from Europe, US, South East Asia  : currency risk remains.
  • Stringent regulatory control+price legislations + forex fluctuations + higher input costs becomes a challenge.

No comments:

Post a Comment